Prof Dr Kathrin de la Rosa

Kathrin de la Rosa (born Kathrin Pieper in 1984) became an immunologist after completing her doctoral studies in 2013 at the University Medical Center Freiburg on B cell disorders in immunodeficient patients. As a postdoctoral fellow, she decided to study monoclonal antibodies in infectious diseases. To this end, she joined the research group of Antonio Lanzavecchia at the Institute for Research in Biomedicine in Switzerland. In 2018, she started her own research group at the Max Delbrück Center in the Helmholtz Association (MDC) in Berlin after being awarding the Emmy Noether Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). In 2020, she was awarded the European Research Council (ERC) starting grant and was selected to obtain the Johanna Quandt Fellowship of the Stiftung Charité. She became a W2 Professor of “Immune mechanisms in translation” at the Berlin Institute of Health@Charité in 2021 and, since 2024, is a W3 Professor of Personalized Immunotherapy (W3) at the Hannover Medical School (MHH) in a joint appointment with the Helmholtz Centre for Infection Research (HZI). She is running her research group at the Centre for Individualised Infection Medicine (CiiM).

Publications

A complete list of publications can be found in the ORCID profile of Kathrin de la Rosa.